Related Experiment Video
Updated: Jun 12, 2026

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Reduced adenosine deaminase activity in the CNS of spontaneously-hypertensive rats
L P Davies1, J W Hambley, G A Johnston
1Department of Pharmacology, University of Sydney, NSW 2006, Australia.
Insights
Adenosine deaminase (ADA) activity is reduced in the brains of spontaneously hypertensive rats (SHR), particularly in the hypothalamus, even before significant hypertension develops. This brain-specific reduction suggests a potential role for ADA in hypertension development.
Area of Science:
- Neuroscience
- Biochemistry
- Cardiovascular Science
Background:
- Spontaneously hypertensive rats (SHR) are a widely used animal model for studying human hypertension.
- Adenosine deaminase (ADA) is an enzyme involved in purine metabolism, with potential roles in neurological and cardiovascular functions.
Purpose of the Study:
- To investigate the activity of adenosine deaminase (ADA) in different brain regions and peripheral organs of spontaneously hypertensive rats (SHR) compared to normotensive WKY controls.
- To determine if changes in ADA activity precede or coincide with the development of hypertension in SHR.
Main Methods:
- Adenosine deaminase (ADA) activity was measured in tissue extracts from the hypothalamus, pons medulla, cerebral cortex, heart, and kidney of 30-day-old and 100-day-old SHR and WKY rats.
- Enzyme activity was quantified using spectrophotometric assays.
- Heat inactivation experiments were performed on pons medulla extracts to confirm enzyme specificity.
Main Results:
- A significant reduction in ADA activity was observed in the hypothalamus (18.0%), pons medulla (20.6%), and cerebral cortex (14.7%) of 100-day-old SHR compared to WKY controls.
- In 30-day-old SHR, a small but significant reduction in hypothalamic ADA activity (9.2%) was detected, while cerebral cortex and pons medulla showed no significant changes.
- No significant reduction in ADA activity was found in the heart or kidney of SHR at either age.
Conclusions:
- These findings indicate a brain-specific reduction in adenosine deaminase (ADA) activity in spontaneously hypertensive rats (SHR).
- The observed decrease in hypothalamic ADA activity in pre-hypertensive SHR suggests a potential role for this enzyme in the early stages of hypertension development.
- ADA activity in peripheral organs like the heart and kidney does not appear to be significantly affected by the hypertensive state in this model.
Abstract:
The activity of adenosine deaminase (ADA) has been measured in the hypothalamus, pons medulla and cerebral cortex from 30-day-old and 100-day-old spontaneously-hypertensive rats (SHR) and age-matched WKY controls. At 100 days there was a significant reduction in ADA activity in the hypothalamus (18.0%), pons medulla (20.6%) and cerebral cortex (14.7%). In 30-day-old SHR animals (prior to the development of significant hypertension) no significant changes were seen in the cerebral cortex or pons medulla but there was a small but significant reduction in ADA activity in the hypothalamus (9.2%). There was no significant reduction in the ADA activity in heart or kidney. Extracts of 100-day-old pons medulla which had been briefly heated to destroy endogenous ADA activity did not differentially affect the activity of exogenous purified ADA.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin II Receptor Blockers
